The Exchange has sought clarification from Zota Health Care LImited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.

ZOTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.1%Reaction day

₹1365.30

prior close

₹1325.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+0.7% vs market

Pharmaceuticals peers, median of 154sector-0.3%+1.3% vs sector

On the reaction day the stock moved 0.7 pts more than Nifty Microcap 250 and 1.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+0.1

15m

+0.4

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.1+0.4+0.7-0.3+1.3

Next day

-1.2+0.3-1.5-0.2-1.0

-4.4-0.1-4.3-0.6-3.7

-5.4-1.4-4.0-1.6-3.9

-7.3-4.1-3.3-3.6-3.7

-12.5-4.8-7.7-4.8-7.8

-3.3-5.4+2.1-4.8+1.5

15d

-5.1+0.7-5.7-2.4-2.7

+2.7+0.9+1.8-2.6+5.3

-17.8-9.1-8.7-9.7-8.1

-4.1-1.2-2.8-4.8+0.7

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 154Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NSE has asked Zota Health Care to explain why its financial results for the quarter ended 30 September 2025 were not submitted in the format prescribed by SEBI under Regulation 33 of the Listing Obligations and Disclosure Requirements. The issue appears to be a formatting technicality rather than a problem with the numbers themselves. The company's response is still awaited.

Likely market impact

This is a procedural clarification request and not a penalty or enforcement action, so near-term impact on the stock is likely limited. However, repeated non-compliance with SEBI reporting formats can attract stricter regulatory scrutiny.